Hodogaya Chemical raised its ordinary profit forecast for the current fiscal year from its previous estimate, revising full-year guidance to ¥4.5 billion and a 6% increase in profit. Second-half profit is estimated at approximately ¥930 million.
Hodogaya Chemical announced its earnings on 11 November. Ordinary profit for the latest cumulative July–September period (2Q) was ¥1.68 billion, up 2.9-fold year on year. Both revenue and operating profit margin improved, with operating profit of ¥4,354 million, revenue of ¥26,607 million and ordinary profit of ¥4,413 million.
The company raised its full-year ordinary profit forecast from ¥3.3 billion to ¥4.5 billion, forecasting a 6.4% increase in profit and exceeding the previous fiscal year’s actual result of ¥4.22 billion. It said there would be no change to its forecast year-end dividend of ¥30 per share for the fiscal year ending March 2027. Based on actual first-half results and the full-year plan, the second-half outlook is difficult to estimate, and the company has factored in the impact of SFC’s listing-related expenses and the delayed consolidation of Framochem.
The company disclosed that second-half ordinary profit for October–March is expected to fall 60.8% year on year to ¥930 million. Although full-year earnings have been revised upward, uncertainty remains in the outlook for the second half.